Activity-based probes that target diverse cysteine protease families
暂无分享,去创建一个
Matthew Bogyo | M. Bogyo | T. Nazif | G. Salvesen | G. Blum | Guy S Salvesen | Galia Blum | K. Boatright | C. Ryan | K. Chehade | Kelly M Boatright | Daisuke Kato | Alicia B Berger | Tamim Nazif | Ciara Ryan | Kareem A H Chehade | D. Kato | A. B. Berger
[1] A. Barrett,et al. Inhibition of Mammalian Legumain by Michael Acceptors and AzaAsn-Halomethylketones , 2002, Biological chemistry.
[2] Alan J. Barrett,et al. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation , 1998, Nature.
[3] J. Powers,et al. Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases , 2003 .
[4] G. Salvesen,et al. Mechanisms of caspase activation. , 2003, Current opinion in cell biology.
[5] B. Manoury,et al. Novel Cell-Permeable Acyloxymethylketone Inhibitors of Asparaginyl Endopeptidase , 2003, Biological chemistry.
[6] N. Thornberry,et al. A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.
[7] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[8] K. Tomoo,et al. Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor. , 1992, Journal of molecular biology.
[9] F. Trotta,et al. PREPARATION AND CHARACTERIZATION OF , 1996 .
[10] P. Griffin,et al. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. , 1994, Biochemistry.
[11] G. Salvesen,et al. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. , 2000, The Biochemical journal.
[12] N. Rawlings,et al. Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases , 1998, FEBS letters.
[13] D. Turk,et al. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.
[14] M. Bogyo,et al. Activity-Based Protein Profiling , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[15] G. Salvesen,et al. Caspases: preparation and characterization. , 1999, Methods.
[16] J C Reed,et al. Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.
[17] Anna E Speers,et al. Chemical Strategies for Activity‐Based Proteomics , 2004, Chembiochem : a European journal of chemical biology.
[18] C. Watts,et al. Multistep Autoactivation of Asparaginyl Endopeptidase in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.
[19] S Toba,et al. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. , 2000, Chemistry & biology.
[20] A. Wendel,et al. The short prodomain influences caspase-3 activation in HeLa cells. , 2000, Biochemical Journal.
[21] G. Zurawski,et al. Autocatalytic activation of human legumain at aspartic acid residues , 1998, FEBS letters.
[22] Kim Nasmyth,et al. Cleavage of Cohesin by the CD Clan Protease Separin Triggers Anaphase in Yeast , 2000, Cell.
[23] A. Barrett,et al. Activation of human prolegumain by cleavage at a C-terminal asparagine residue. , 2000, Biochemical Journal.
[24] J. Ellman,et al. Synthesis of a diverse library of mechanism-based cysteine protease inhibitors. , 2003, Journal of combinatorial chemistry.
[25] Jonathan A. Ellman,et al. General Solid-Phase Method for the Preparation of Mechanism-Based Cysteine Protease Inhibitors , 1999 .
[26] G. Salvesen,et al. Human Caspase-7 Activity and Regulation by Its N-terminal Peptide* , 2003, Journal of Biological Chemistry.
[27] T. Fox,et al. Modification of S1 subsite specificity in the cysteine protease cathepsin B. , 1995, Protein engineering.